Eviplera

DRUG2 trials

Sponsors

UMC Utrecht, St Stephens Aids Trust

Conditions

HIVHIV Associated Neurocognitive DisorderNeurocognitive Decline

Phase 4

Effect of SwitChing AtriPla to Eviplera on Neurocognitive and Emotional Functioning

CompletedNCT02308332

UMC UtrechtHIV Associated Neurocognitive Disorder, Neurocognitive Decline

Start: 2015-02-28End: 2017-06-30Updated: 2017-10-27

SSAT058: Atripla to Eviplera Switch in Patients Without Central Nervous System Symptoms

CompletedNCT02529059

St Stephens Aids TrustHIV

Start: 2015-11-30End: 2017-05-31Target: 40Updated: 2017-09-18

Related Papers

Underlying Neural Mechanisms of Cognitive Improvement in Fronto-striatal Response Inhibition in People Living with HIV Switching Off Efavirenz: A Randomized Controlled BOLD fMRI Trial.

2024-04-202 citations